US5082655A
(en)
*
|
1984-07-23 |
1992-01-21 |
Zetachron, Inc. |
Pharmaceutical composition for drugs subject to supercooling
|
US4629621A
(en)
*
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
US4764378A
(en)
*
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
US4780236A
(en)
*
|
1986-06-20 |
1988-10-25 |
Kiwi Brands, Inc. |
Lavoratory cleansing block containing polyethylene gycol disteatrate, guar gum and sodium chloride
|
US4804400A
(en)
*
|
1986-09-12 |
1989-02-14 |
Ciba-Geigy Corporation |
N-phenyl-maleimides and herbicidal and plant growth regulating methods of use thereof
|
US5310572A
(en)
*
|
1987-02-03 |
1994-05-10 |
Dow Corning Corporation |
Process for forming a coated active agent-containing article
|
US4843112A
(en)
*
|
1987-03-12 |
1989-06-27 |
The Beth Israel Hospital Association |
Bioerodable implant composition
|
US5085861A
(en)
*
|
1987-03-12 |
1992-02-04 |
The Beth Israel Hospital Association |
Bioerodable implant composition comprising crosslinked biodegradable polyesters
|
ES2054784T3
(es)
*
|
1987-08-08 |
1994-08-16 |
Akzo Nv |
Un metodo para la fabricacion de un implante.
|
US5137669A
(en)
*
|
1988-03-02 |
1992-08-11 |
Endocon, Inc. |
Manufacture of partially fused peptide pellet
|
US5028477A
(en)
*
|
1988-03-04 |
1991-07-02 |
The Dow Chemical Company |
Carbonaceous fiber or fiber assembly with inorganic coating
|
US4978571A
(en)
*
|
1988-03-04 |
1990-12-18 |
The Dow Chemical Company |
Carbonaceous fiber or fiber assembly with inorganic coating
|
US5034267A
(en)
*
|
1988-03-04 |
1991-07-23 |
The Dow Chemical Company |
Carbonaceous fiber or fiber assembly with inorganic coating
|
US4944999A
(en)
*
|
1988-03-04 |
1990-07-31 |
The Dow Chemical Company |
Carbonaceous fiber or fiber assembly with inorganic coating
|
WO1989009066A1
(en)
*
|
1988-03-24 |
1989-10-05 |
Bukh Meditec A/S |
Controlled release composition
|
US5004601A
(en)
*
|
1988-10-14 |
1991-04-02 |
Zetachron, Inc. |
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
US5139790A
(en)
*
|
1988-10-14 |
1992-08-18 |
Zetachron, Inc. |
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
US5135752A
(en)
*
|
1988-10-14 |
1992-08-04 |
Zetachron, Inc. |
Buccal dosage form
|
SE8803935L
(sv)
*
|
1988-10-31 |
1990-05-01 |
Kabivitrum Ab |
Laekemedelskomposition
|
JP2893191B2
(ja)
*
|
1988-11-08 |
1999-05-17 |
武田薬品工業株式会社 |
放出制御性マトリックス剤
|
DE3933000A1
(de)
*
|
1989-10-03 |
1991-04-11 |
Int Pharma Agentur |
Erosionsgesteuertes wirkstoff-freigabesystem und verfahren zu seiner herstellung
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
DK469989D0
(da)
*
|
1989-09-22 |
1989-09-22 |
Bukh Meditec |
Farmaceutisk praeparat
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
CA2031313C
(en)
*
|
1990-12-03 |
2000-09-05 |
Barry R. Pittendrigh |
Method of mosquito control
|
US5403593A
(en)
*
|
1991-03-04 |
1995-04-04 |
Sandoz Ltd. |
Melt granulated compositions for preparing sustained release dosage forms
|
US5302393A
(en)
*
|
1991-07-11 |
1994-04-12 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
Method for inhibiting biological degradation of implantation polymeric material, inhibitor thereof and implantation polymeric material containing the inhibitor
|
EP0596962A4
(en)
*
|
1991-07-24 |
1997-01-15 |
Enzacor Pty Ltd |
Therapeutic compositions and methods.
|
US5335449A
(en)
*
|
1991-08-15 |
1994-08-09 |
Net/Tech International, Inc. |
Delivery system for an agriculturally active chemical
|
US5526607A
(en)
*
|
1991-08-15 |
1996-06-18 |
Net/Tech International |
Water dispersible delivery system for an agriculturally active chemical
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
PT661045E
(pt)
*
|
1992-09-18 |
2002-11-29 |
Yamanouchi Pharma Co Ltd |
Preparacao em hidrogel de libertacao prolongada
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
US6191105B1
(en)
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
US5681811A
(en)
*
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5430021A
(en)
*
|
1994-03-18 |
1995-07-04 |
Pharmavene, Inc. |
Hydrophobic drug delivery systems
|
US5484608A
(en)
*
|
1994-03-28 |
1996-01-16 |
Pharmavene, Inc. |
Sustained-release drug delivery system
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
US5599583A
(en)
*
|
1994-05-27 |
1997-02-04 |
Micro Flo Company |
Encapsulation with water soluble polymer
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5703073A
(en)
*
|
1995-04-19 |
1997-12-30 |
Nitromed, Inc. |
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
GB9519363D0
(en)
*
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
US5783212A
(en)
*
|
1996-02-02 |
1998-07-21 |
Temple University--of the Commonwealth System of Higher Education |
Controlled release drug delivery system
|
ATE427124T1
(de)
|
1996-06-26 |
2009-04-15 |
Univ Texas |
Heiss-geschmolzene extrudierbare pharmazeutische formulierung
|
US5868991A
(en)
*
|
1996-07-26 |
1999-02-09 |
Kimberly-Clark Worldwide, Inc. |
Method for low temperature injection molding of hydrodisintegratable compositions
|
US6703381B1
(en)
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
DE19916383A1
(de)
*
|
1999-03-31 |
2000-10-05 |
Schering Ag |
Pharmazeutische Zusammensetzung mit einem Extrusionsstoff
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
JP4902918B2
(ja)
|
1999-07-30 |
2012-03-21 |
スミスクライン ビーチャム ピー エル シー |
多成分医薬剤形
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
US6264981B1
(en)
*
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
KR20130010512A
(ko)
|
1999-10-29 |
2013-01-28 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
US6503528B1
(en)
|
1999-11-19 |
2003-01-07 |
Abbott Laboratories |
Polymeric compositions and a method of making the same
|
US6475505B1
(en)
*
|
1999-12-20 |
2002-11-05 |
Ciba Specialty Chemicals Corporation |
Biocide-polyester concentrates and biocidal compositions prepared therefrom
|
US6544553B1
(en)
*
|
1999-12-28 |
2003-04-08 |
Watson Pharmaceuticals, Inc. |
Dosage forms and methods for oral delivery of progesterone
|
US6419954B1
(en)
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
DE10026698A1
(de)
*
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
KR100968128B1
(ko)
|
2000-10-30 |
2010-07-06 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
US6756051B1
(en)
|
2000-11-15 |
2004-06-29 |
Li-Lan H. Chen |
Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
|
AU2002236495B2
(en)
*
|
2000-11-29 |
2006-05-11 |
Allergan, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
GB0102342D0
(en)
*
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US20050175687A1
(en)
*
|
2001-01-30 |
2005-08-11 |
Mcallister Stephen M. |
Pharmaceutical formulations
|
US7842308B2
(en)
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US20040067256A1
(en)
*
|
2001-02-13 |
2004-04-08 |
Anne Juppo |
Novel modified release formulation
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
WO2002089853A2
(en)
*
|
2001-05-03 |
2002-11-14 |
Allergan, Inc. |
Compositions having enhanced pharmacokinetic characteristics
|
US20020198210A1
(en)
*
|
2001-05-03 |
2002-12-26 |
Allergan Sales Inc. |
Alpha-2-adrenergic agonist/fatty acid compositions
|
US20020198209A1
(en)
|
2001-05-03 |
2002-12-26 |
Allergan Sales Inc. |
Compositions having enhanced pharmacokinetic characteristics
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
KR100446818B1
(ko)
*
|
2001-11-06 |
2004-09-01 |
김재윤 |
질산 이소소르비드 서방성 펠렛 제형
|
AU2003218127B2
(en)
*
|
2002-03-11 |
2007-07-12 |
Alcon, Inc. |
Implantable drug delivery system
|
AU2003236521A1
(en)
*
|
2002-06-13 |
2003-12-31 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20050100608A1
(en)
*
|
2003-02-21 |
2005-05-12 |
Watson Pharmaceuticals, Inc. |
Testosterone oral dosage formulations and associated methods
|
US7442387B2
(en)
*
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
US20050042289A1
(en)
*
|
2003-04-29 |
2005-02-24 |
Yamanouchi Pharma Technologies, Inc. |
Tablets and methods for modified release of hydrophylic and other active agents
|
US7135436B2
(en)
*
|
2003-05-05 |
2006-11-14 |
J.F. Daley International, Ltd. |
Solid algicide, preparation and usage in recirculating water
|
TW200526274A
(en)
|
2003-07-21 |
2005-08-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
EP1842533B1
(de)
*
|
2003-08-06 |
2013-05-01 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
RS20060132A
(en)
*
|
2003-08-08 |
2008-06-05 |
Biovail Laboratories International Srl., |
Modified-release tablet of bupropion hydrochloride
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
US8377952B2
(en)
*
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
TW200539903A
(en)
*
|
2004-03-12 |
2005-12-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
EP1591107A1
(de)
*
|
2004-04-28 |
2005-11-02 |
Pfizer GmbH Arzneimittelwerk Gödecke |
Verfahren zur selektiven Zunahme der Freisetzungsrate eines aktiven Materials aus einer pharmazeutischen Zubereitung
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
AU2005269753B2
(en)
*
|
2004-07-19 |
2011-08-18 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
DK1836665T3
(da)
|
2004-11-19 |
2013-04-15 |
Glaxosmithkline Llc |
Fremgangsmåde til specialtilpasset afgivelse af medikamentkombinationsprodukter med variabel dosis til individualisering af terapier
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
CN101534808A
(zh)
|
2005-06-27 |
2009-09-16 |
拜维尔实验室国际有限公司 |
丁氨苯丙酮盐的改良释放配制品
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
CA2671197A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophobic abuse deterrent delivery system
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
JP5190515B2
(ja)
*
|
2007-10-15 |
2013-04-24 |
カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ |
充填リンカーを製造する方法および装置
|
WO2009050190A2
(en)
|
2007-10-15 |
2009-04-23 |
Glaxo Group Limited |
Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms
|
WO2009050192A1
(en)
*
|
2007-10-15 |
2009-04-23 |
Glaxo Group Limited |
Paneled capsule shells for release of pharmaceutical compositions
|
MX2010003979A
(es)
*
|
2007-10-16 |
2010-06-02 |
Biocon Ltd |
Composicion farmaceutica oralmente administrable y proceso para su preparacion.
|
EP2219624A2
(de)
|
2007-11-08 |
2010-08-25 |
Glaxo Group Limited |
Pharmazeutische formulierungen
|
NZ586792A
(en)
|
2008-01-25 |
2012-09-28 |
Gruenenthal Chemie |
Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
US9107815B2
(en)
*
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
ES2599031T3
(es)
|
2008-05-09 |
2017-01-31 |
Grünenthal GmbH |
Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
|
CN102119026A
(zh)
*
|
2008-06-13 |
2011-07-06 |
葛兰素集团有限公司 |
羟丙基纤维素胶囊壳
|
BRPI0917206B1
(pt)
*
|
2008-07-31 |
2018-04-17 |
Clarke Mosquito Control Products, Inc. |
Método para a formação de uma pastilha comprimida de liberação dupla, pastilhas comprimidas e método para a fabricação de uma matriz sólida de liberação prolongada
|
US20110020451A1
(en)
|
2009-07-22 |
2011-01-27 |
Grunenthal Gmbh |
Tamper-resistant dosage form for oxidation-sensitive opioids
|
AU2010275753B2
(en)
|
2009-07-22 |
2014-08-21 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
WO2011040956A1
(en)
*
|
2009-09-29 |
2011-04-07 |
Michael Burnet |
Novel pesticide formulations
|
WO2011095314A2
(en)
|
2010-02-03 |
2011-08-11 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
CN103269688A
(zh)
|
2010-09-02 |
2013-08-28 |
格吕伦塔尔有限公司 |
包含无机盐的抗破碎剂型
|
EP2611425B1
(de)
|
2010-09-02 |
2014-07-02 |
Grünenthal GmbH |
Manipulationssichere darreichungsform mit einem anionischen polymer
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
EP2651399A2
(de)
|
2010-12-13 |
2013-10-23 |
Purdue Pharma LP |
Retard-darreichungsformen
|
HUE034710T2
(hu)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Visszaéléssel szemben ellenálló, azonnali hatóanyagfelszabadulást biztosító tabletta
|
ES2655900T3
(es)
|
2011-07-29 |
2018-02-22 |
Grünenthal GmbH |
Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
|
WO2013127831A1
(en)
|
2012-02-28 |
2013-09-06 |
Grünenthal GmbH |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
SI2838512T1
(sl)
|
2012-04-18 |
2018-11-30 |
Gruenenthal Gmbh |
Pred posegi in prehitrim sproščanjem odporna farmacevtska oblika odmerka
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
WO2014191396A1
(en)
|
2013-05-29 |
2014-12-04 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
BR112015026549A2
(pt)
|
2013-05-29 |
2017-07-25 |
Gruenenthal Gmbh |
forma de dosagem à prova de violação contendo uma ou mais partículas
|
CN105682643B
(zh)
|
2013-07-12 |
2019-12-13 |
格吕伦塔尔有限公司 |
含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
|
MX371372B
(es)
|
2013-11-26 |
2020-01-28 |
Gruenenthal Gmbh |
Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
|
AU2015261060A1
(en)
|
2014-05-12 |
2016-11-03 |
Grunenthal Gmbh |
Tamper resistant immediate release capsule formulation comprising Tapentadol
|
US9872835B2
(en)
|
2014-05-26 |
2018-01-23 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
US10653622B1
(en)
|
2015-04-13 |
2020-05-19 |
Pharmacoustics Technologies LLC |
Individualized solid dosage products and a system and method for the globally integrated pharmaceutical manufacturing and its monitoring thereof
|
MX2017013637A
(es)
|
2015-04-24 |
2018-03-08 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
EP3703724A1
(de)
|
2017-11-02 |
2020-09-09 |
NatureCeuticals Sdn. Bhd. |
Extrakt aus orthosiphon stamineus, formulierungen und verwendungen davon
|